{
  "document_id": "BIOAMBERINC_04_10_2013-EX-10.34-DEVELOPMENT AGREEMENT (1)",
  "file_path": "data/CUAD_v1/full_contract_pdf/Part_II/Development/BIOAMBERINC_04_10_2013-EX-10.34-DEVELOPMENT AGREEMENT (1).pdf",
  "text_length": 38983,
  "chunk_count": 52,
  "vector_store_path": "output/vector_stores/BIOAMBERINC_04_10_2013-EX-10.34-DEVELOPMENT AGREEMENT (1)",
  "summary": "Law), and 13.7  (Survivability) will survive the expiration or earlier termination of this Development Agreement. \n13.8 Entire Agreement . This Development Agreement supersedes all previous understandings between Cargill and Bioamber concerning the \nsubject matter of this  Development Agreement, including but not limited to the Term Sheet executed by the Parties on December 3, 2009 \nand December 4, 2009, and the Mutual Confidentiality Agreement between the Parties which was effective July 17, 2009, and,  together with \nits attachments, including the Commercial License Agreement attached hereto as Exhibit D executed concurrently with this Development \nAgreement, contains the entire agreement between the parties with respect to the subject matter  hereof, and may not be amended, modified, \nor supplemented except in writing and signed by both Parties specifically referring to this Development Agreement and the Commercial \nLicense Agreement.\n\nMilestone 3 is delivered by or before the Target Date, then the total payments due to Cargill at that time would be  [***] (a total \npayment of $[***]). Another example is if [***], the payment due at that time would be a total of $[***]. \n\u00a02.4.2 In the event Cargill does not achieve a given Milestone provided in Section 2.3 by the Target Date listed in Section 2.3 or modified \nMilestone and modified  Target Date as agreed to by the Parties, and Bioamber decides to commercialize Modified CB1, any \noutstanding milestone payments shall immediately become due such that the total payment due Cargill under this Development \nAgreement equals One Million  Fifty Thousand U.S. Dollars (US $1,050,000.00).\n\n7. Warranties . Except as provided in Section 1.2 of this Development Agreement, Cargill makes no representations or warranties, express or \nimplied, with  respect to the services provided under this Development Agreement and with respect to the subject matter of this \nDevelopment Agreement. The services are provided \u201cas is\u201d\u00a0and Bioamber acknowledges that it bears all responsibility and  accountability \nfor evaluating, approving, and implementing any of results resulting from this Development Agreement. \n8. Indemnification . Bioamber and Cargill agree to waive any and all claims against each other for consequential, punitive, incidental, special, or \nother forms of  \u201cexemplary \u201d\u00a0losses whether arising in contract, warranty, tort (including negligence), strict liability, or otherwise, including \nany losses relating to lost use, lost profits, lost business, damage to reputation, or lost or diminished  financing unless such claims are\n\nEXHIBIT D  \nCOMMERCIAL LICENSE AGREEMENT  \n\u00a0 \nCargill  Confidential  \n- 16 -  \n* Confidential treatment requested \n\n\nEXHIBIT E  \nThird Party Patents relating to the Work Plan  \n\u00a0 \nThird Party Patents relating to Modified Work Plan  \n\u00a0 \n\u00a0 \nCargill  Confidential  \n- 17 -  \n* Confidential treatment requested Publication number and title \u00a0Assignee\n[***] \u00a0\nPublication number and title \u00a0Assignee\n[***]",
  "parties": "acting in good faith, have settled such dispute in writing between themselves or through an  independent expert. \n11. Independent Contractor . Nothing in this Development Agreement is to be construed to deem the relationship between the parties to be one \nof master/servant,  principal/agent, or employer/employee. To the contrary, the relationship of Cargill to Bioamber is that of independent \ncontractor, and Cargill will have no authority to (i) make any binding decision for, or on behalf of, Bioamber or  (ii) commit Bioamber to any \ncontract, obligation, debt, or other liability. None of Cargill \u2019s employees will be deemed to be employees of Bioamber. \n12. Publicity . Any public statements related to work performed under this Development Agreement, including public statements related to the \nexistence of this  Development Agreement itself, will only be made after the prior written consent of both Parties concerning timing, content, \nand audience.\n\nperform or continue to perform the Work Plan and the next steps if such licenses are needed. \n13.2 Governing Law . This Development Agreement shall be governed by and construed in accordance with the laws of the State of Minnesota, \nUnited States of America,  disregarding its conflicts of law rules. \n13.3 Assignment . Neither Party shall assign this Development Agreement or the obligations contained herein without the express written \nconsent of the other Party.  \n13.4 Waiver . The failure of either Party to insist in any one or more instances upon performance of any terms or conditions of this Development \nAgreement, is not to  be construed as a waiver of future performance of any such term, covenant, or condition, but the obligations of either \nParty with respect thereto will continue in full force and effect. No waiver will be effective unless in writing and signed by the  waiving \nParty.\n\nParty with respect thereto will continue in full force and effect. No waiver will be effective unless in writing and signed by the  waiving \nParty. \n13.5 Amendment . No amendment, modification, or waiver of the terms of this Development Agreement shall be binding unless placed in writing \nand duly executed by the  Parties\u2019\u00a0authorized representatives. \n13.6 Severability . All provisions contained herein are severable, and in the event any of them is held to be invalid by any competent court or \narbitrator, this  Development Agreement is to be interpreted as if such invalid provision were not contained herein. \n13.7 Survivability . Sections 4 (Confidentiality), 5 (Intellectual Property), 6 (WRF Patents), 7 (Warranties), 8 (Indemnification), 13.2 (Governing \nLaw), and 13.7  (Survivability) will survive the expiration or earlier termination of this Development Agreement.\n\nAgreement. \n4.3 The Receiving Party shall not disclose the Disclosing Party \u2019s Confidential Information to any unauthorized party without the Disclosing \nParty\u2019s prior express  written consent or unless required by court order or order of a similar governmental entity. If a Party is required by \ncourt order or order of a similar governmental entity to disclose the other \u2019s Confidential Information, they shall give the  other Party prompt \nnotice of such requirement so that an appropriate protective order or other relief may be sought. \n4.4 The Receiving Party will use Confidential Information only in connection with the Work Plan. Both Parties have reserved all rights to their \nrespective Confidential  Information not expressly granted herein. All documents and/or tangible materials containing or comprising \nConfidential Information of the Disclosing Party will remain the property of the Disclosing Party. Upon the request of the Disclosing Party,",
  "key_terms": "Party with respect thereto will continue in full force and effect. No waiver will be effective unless in writing and signed by the  waiving \nParty. \n13.5 Amendment . No amendment, modification, or waiver of the terms of this Development Agreement shall be binding unless placed in writing \nand duly executed by the  Parties\u2019\u00a0authorized representatives. \n13.6 Severability . All provisions contained herein are severable, and in the event any of them is held to be invalid by any competent court or \narbitrator, this  Development Agreement is to be interpreted as if such invalid provision were not contained herein. \n13.7 Survivability . Sections 4 (Confidentiality), 5 (Intellectual Property), 6 (WRF Patents), 7 (Warranties), 8 (Indemnification), 13.2 (Governing \nLaw), and 13.7  (Survivability) will survive the expiration or earlier termination of this Development Agreement.\n\nperform or continue to perform the Work Plan and the next steps if such licenses are needed. \n13.2 Governing Law . This Development Agreement shall be governed by and construed in accordance with the laws of the State of Minnesota, \nUnited States of America,  disregarding its conflicts of law rules. \n13.3 Assignment . Neither Party shall assign this Development Agreement or the obligations contained herein without the express written \nconsent of the other Party.  \n13.4 Waiver . The failure of either Party to insist in any one or more instances upon performance of any terms or conditions of this Development \nAgreement, is not to  be construed as a waiver of future performance of any such term, covenant, or condition, but the obligations of either \nParty with respect thereto will continue in full force and effect. No waiver will be effective unless in writing and signed by the  waiving \nParty.\n\nLaw), and 13.7  (Survivability) will survive the expiration or earlier termination of this Development Agreement. \n13.8 Entire Agreement . This Development Agreement supersedes all previous understandings between Cargill and Bioamber concerning the \nsubject matter of this  Development Agreement, including but not limited to the Term Sheet executed by the Parties on December 3, 2009 \nand December 4, 2009, and the Mutual Confidentiality Agreement between the Parties which was effective July 17, 2009, and,  together with \nits attachments, including the Commercial License Agreement attached hereto as Exhibit D executed concurrently with this Development \nAgreement, contains the entire agreement between the parties with respect to the subject matter  hereof, and may not be amended, modified, \nor supplemented except in writing and signed by both Parties specifically referring to this Development Agreement and the Commercial \nLicense Agreement.\n\n7. Warranties . Except as provided in Section 1.2 of this Development Agreement, Cargill makes no representations or warranties, express or \nimplied, with  respect to the services provided under this Development Agreement and with respect to the subject matter of this \nDevelopment Agreement. The services are provided \u201cas is\u201d\u00a0and Bioamber acknowledges that it bears all responsibility and  accountability \nfor evaluating, approving, and implementing any of results resulting from this Development Agreement. \n8. Indemnification . Bioamber and Cargill agree to waive any and all claims against each other for consequential, punitive, incidental, special, or \nother forms of  \u201cexemplary \u201d\u00a0losses whether arising in contract, warranty, tort (including negligence), strict liability, or otherwise, including \nany losses relating to lost use, lost profits, lost business, damage to reputation, or lost or diminished  financing unless such claims are"
}